AN UNBIASED VIEW OF AGO TUMOR

Molecular typing is based on molecular genetic testing and isn't nevertheless routinely obtainable. Molecular subtypes and immunohistochemical surrogate markers with the tumors (HR, HER2, triple negative) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-67 might be beneficial, bu